Press "Enter" to skip to content

Type 2 Diabetes Patients Might Benefit From Eggs Breakfast

Generally, a few cereals might be used as a breakfast of champions. However, Jonathan Little, Associate Professor, School of Health and Exercise Sciences, UBC Okanagan, highlights that individuals suffering from Type 2 Diabetes (T2D) should get something else for breakfast. In a recently published research, Little demonstrated that a high-fat, low-carb breakfast (LCBF) might assist those with T2D manage their blood sugar levels during the day.

Little proclaimed that the huge blood sugar spike following breakfast is owing to the blend of pronounced insulin resistance in the morning in individuals suffering from T2D and due to usual Western breakfast foods such as oatmeal, cereal, fruit, and toast. These food items are known for containing high carbohydrates. He added that Breakfast is consistently the “issue” meal that leads to the biggest blood sugar spikes for T2D individuals. His research highlights that LCBF is a simple technique to avoid this huge spike and advance glycemic control throughout the day. He added that it might as well minimize other diabetes problems.

On a similar note, a new study came into the news as it highlighted that a widespread prostate cancer medication has been associated with T2D. Men consuming 5-alpha-reductase inhibitors were found at increased risk to develop T2D by a third. This research can be accessed in The British Medical Journal.

Ruth Andrew, Researcher University of Edinburgh, is the senior author of the study. In a news release, she highlighted that normally prescribed drugs for the prostate disease might enlarge the risk of T2D. She added that these findings will be specifically important for health screening in older men with an increased risk of T2D. Andrew assured that the research team will continue its studies to better comprehend the long-period outcomes so they can better spot patients at higher risk. The researchers discovered that men in the U.K. and Taiwan who used finasteride or dutasteride to treat mild prostatic hyplasia had an approximately 30% spike in T2D.

Ashley Klapper
EDITOR & AUTHOR At World Industry Insights

Ashley Klapper is engaged in writing all news related to the health domain. Her in-depth knowledge in the health sector and punctuality helps her to lead the health department at World Industry Insights effortlessly. She holds experience of almost 3 years in the field. Ashley covers all news in the health sector including the latest research, inventions, and novel technologies introduced in the field. When she is not working, Ashley loves to do classical dance practice.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *